BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30636238)

  • 1. [Progressive familial intrahepatic cholestasis type 3].
    Lipiński P; Jankowska I
    Dev Period Med; 2018; 22(4):385-389. PubMed ID: 30636238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
    Yeap SP; Harley H; Thompson R; Williamson KD; Bate J; Sethna F; Farrell G; Hague WB
    J Gastroenterol Hepatol; 2019 Feb; 34(2):425-435. PubMed ID: 29992621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
    Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
    J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
    van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
    Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
    BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCB4 disease: Many faces of one gene deficiency.
    Sticova E; Jirsa M
    Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductopenia and cirrhosis in a 32-year-old woman with progressive familial intrahepatic cholestasis type 3: A case report and review of the literature.
    Tan YW; Ji HL; Lu ZH; Ge GH; Sun L; Zhou XB; Sheng JH; Gong YH
    World J Gastroenterol; 2018 Nov; 24(41):4716-4720. PubMed ID: 30416319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
    Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
    Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive familial intrahepatic cholestasis type 3: Report of four clinical cases, novel ABCB4 variants and long-term follow-up.
    Lipiński P; Ciara E; Jurkiewicz D; Płoski R; Wawrzynowicz-Syczewska M; Pawłowska J; Jankowska I
    Ann Hepatol; 2021; 25():100342. PubMed ID: 33757843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Novel Missense Mutation in
    Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
    Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive familial intrahepatic cholestasis. Genetic basis and treatment.
    Jacquemin E
    Clin Liver Dis; 2000 Nov; 4(4):753-63. PubMed ID: 11232355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial intrahepatic cholestasis: New and wide perspectives.
    Vitale G; Gitto S; Vukotic R; Raimondi F; Andreone P
    Dig Liver Dis; 2019 Jul; 51(7):922-933. PubMed ID: 31105019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutation in a Chinese patient with progressive familial intrahepatic cholestasis type 3.
    Sun HZ; Shi H; Zhang SC; Shen XZ
    World J Gastroenterol; 2015 Jan; 21(2):699-703. PubMed ID: 25593501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
    Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
    BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future therapies for inherited cholestatic liver diseases.
    van der Woerd WL; Houwen RH; van de Graaf SF
    World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report.
    Wu Z; Zhang S; Zhang L; Li M
    Diagn Pathol; 2020 Apr; 15(1):39. PubMed ID: 32321542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
    Aronson SJ; Bakker RS; Shi X; Duijst S; Ten Bloemendaal L; de Waart DR; Verheij J; Ronzitti G; Oude Elferink RP; Beuers U; Paulusma CC; Bosma PJ
    J Hepatol; 2019 Jul; 71(1):153-162. PubMed ID: 30935993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.